Evidence map›Paper›PMID 38150543›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2024

Small airway fibroblasts from patients with chronic obstructive pulmonary disease exhibit cellular senescence.

Catherine L Wrench, Jonathan R Baker, Sue Monkley, Peter S Fenwick, Lynne Murray, Louise E Donnelly, Peter J Barnes

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Hallmarks of the ageing lung: 10 years later.The European respiratory journal · 2026
    Review
  4. Review
  5. Article
  6. Emerging Mechanistic Links Between Fucosylation and Senescence in Lung Diseases.Journal of respiratory biology and translational medicine · 2026
    Article
  7. Review
  8. Review
  9. IFN-Mediated Bronchial Epithelium Cellular Senescence in Chronic Obstructive Pulmonary Disease.American journal of respiratory cell and molecular biology · 2025
    Article
  10. Article
  11. Senescence at the Crossroads of Lung Development and Injury.American journal of respiratory cell and molecular biology · 2025
    Article
  12. Senotherapy for chronic lung disease.Pharmacological reviews · 2025
    Review
  13. Article
  14. Article
  15. Effect of physical activity in lymphocytes senescence burden in patients with COPD.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  16. Unveiling mechanisms of lung aging in COPD: A promising target for therapeutics development.Chinese medical journal pulmonary and critical care medicine · 2024
    Review
  17. Review
  18. Article
  19. Article
  20. Macrophage Dysfunction in Respiratory Disease.Results and problems in cell differentiation · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Catherine L WrenchAirway Disease Section, National Heart and Lung Institute, Imperial College, London, United Kingdom.ORCID 0000-0002-3120-7528
Jonathan R BakerAirway Disease Section, National Heart and Lung Institute, Imperial College, London, United Kingdom.
Sue MonkleyTranslation Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology (R&I), Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Peter S FenwickAirway Disease Section, National Heart and Lung Institute, Imperial College, London, United Kingdom.
Lynne MurrayBioscience COPD/IPF, Research and Early Development, Respiratory & Immunology (R&I), Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
Louise E DonnellyAirway Disease Section, National Heart and Lung Institute, Imperial College, London, United Kingdom.ORCID 0000-0002-0753-5425
Peter J BarnesAirway Disease Section, National Heart and Lung Institute, Imperial College, London, United Kingdom.
Imperial College London · GBAstraZeneca (United Kingdom) · GBAstraZeneca (Sweden) · SE

Funding

AstraZeneca (AstraZeneca PLC)Imperial College London (ICL)Medical Research Council MR/W028069/1UKRI | Biotechnology and Biological Sciences Research Council (BBSRC) BB/L015129/1Wellcome TrustWellcome Trust (WT) 104931/Z/14/ZWellcome Trust (WT) 208340/Z/17/Z
6 · The paper itself

Abstract

Small airway disease (SAD) is a key early-stage pathology of chronic obstructive pulmonary disease (COPD). COPD is associated with cellular senescence whereby cells undergo growth arrest and express the senescence-associated secretory phenotype (SASP) leading to chronic inflammation and tissue remodeling. Parenchymal-derived fibroblasts have been shown to display senescent properties in COPD, however small airway fibroblasts (SAFs) have not been investigated. Therefore, this study investigated the role of these cells in COPD and their potential contribution to SAD. To investigate the senescent and fibrotic phenotype of SAF in COPD, SAFs were isolated from nonsmoker, smoker, and COPD lung resection tissue (

Indexed as

AsthmaMitochondrial DiseasesPulmonary Disease, Chronic ObstructiveCellular SenescenceFibroblastsHumansLungCOPDfibroblastsenescencesmall airway disease

Identifiers

PMID38150543
PMCPMC11281792
OpenAlexW4390263590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.